Vinge advised Cinclus Pharma on the deal. Cinclus Pharma Holding AB (publ) secured an offering of new ordinary shares and listing on Nasdaq Stockholm. The offering...
Cinclus Pharma’s Listing on Nasdaq Stockholm
Svea Bank’s Tier 2 Capital Bonds Offering
Vinge advised Svea Bank AB on the deal. Svea Bank AB secured the issuance of SEK 300 million callable tier 2 capital bonds (T2) with a...
Bilia’s Financing Round
Vinge advised Bilia AB on the deal. Bilia AB (publ) finalized a SEK 2.3 billion refinancing of its existing revolving loan and credit facilities. The new...
Attendo’s Acquisition of Team Olivias Care Operations
Vinge advised Attendo on the deal. Attendo, the largest care company in the Nordic region, closed an agreement to acquire Team Olivia’s Swedish care operations (excluding...
Svea Bank AB’s Additional Tier 1 Capital Offering
Vinge advised Svea Bank AB on the deal. Svea Bank AB completed its issuance of SEK 300 million additional tier 1 capital bonds (AT1) with a...
Region Uppsala’s Health Impact Bonds Offering
Vinge advised Region Uppsala on the offering. Region Uppsala completed the issuance of a so-called health impact bond in the amount of SEK 80 million and with...
Ambea AB’s SEK 5 Billion Refinancing
Vinge advised Ambea AB on the deal. Ambea AB (publ) entered into an unsecured sustainability-linked facility agreement with a bank syndicate comprised of three Nordic banks....